Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126032701 | 12603270 | 1 | I | 20160712 | 20160728 | 20160728 | PER | US-GILEAD-2016-0223719 | GILEAD | 62.00 | YR | A | F | Y | 78.50000 | KG | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126032701 | 12603270 | 1 | PS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, UNK | 204671 | 400 | MG | TABLET | |||||||
| 126032701 | 12603270 | 2 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 126032701 | 12603270 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 126032701 | 12603270 | 4 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | Respiratory (inhalation) | 2 PUFFS, Q 6 HRS PRN | 0 | ||||||||||
| 126032701 | 12603270 | 5 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Oral | 1 DF, Q1WK | 0 | 1 | DF | /wk | |||||||
| 126032701 | 12603270 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF, BID | 0 | BID | |||||||||
| 126032701 | 12603270 | 7 | C | HYDRODIURIL | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 126032701 | 12603270 | 8 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Oral | 1 DF, BID | 0 | 1 | DF | BID | |||||||
| 126032701 | 12603270 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100 MCG, QD | 0 | QD | |||||||||
| 126032701 | 12603270 | 10 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 126032701 | 12603270 | 11 | C | MOBIC | MELOXICAM | 1 | Oral | 15 MG, QD | 0 | 15 | MG | QD | |||||||
| 126032701 | 12603270 | 12 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 126032701 | 12603270 | 13 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126032701 | 12603270 | 1 | Hepatitis C |
| 126032701 | 12603270 | 2 | Hepatitis C |
| 126032701 | 12603270 | 3 | Hepatitis C |
| 126032701 | 12603270 | 4 | Wheezing |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126032701 | 12603270 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126032701 | 12603270 | Drug ineffective | |
| 126032701 | 12603270 | Hepatitis C |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126032701 | 12603270 | 1 | 20140909 | 20141202 | 0 | |
| 126032701 | 12603270 | 2 | 20140909 | 20141125 | 0 | |
| 126032701 | 12603270 | 3 | 20140909 | 20141202 | 0 | |
| 126032701 | 12603270 | 4 | 20140709 | 20150709 | 0 | |
| 126032701 | 12603270 | 5 | 20140430 | 0 | ||
| 126032701 | 12603270 | 6 | 20140709 | 0 | ||
| 126032701 | 12603270 | 7 | 20140430 | 0 | ||
| 126032701 | 12603270 | 8 | 20131031 | 0 | ||
| 126032701 | 12603270 | 9 | 20140519 | 0 | ||
| 126032701 | 12603270 | 10 | 20140709 | 0 | ||
| 126032701 | 12603270 | 11 | 20140430 | 0 | ||
| 126032701 | 12603270 | 12 | 20140709 | 0 | ||
| 126032701 | 12603270 | 13 | 20140709 | 20150709 | 0 |